CRYSTAL ADAM (President, R&D) sold 9.6% of their position (12K shares) of TANGO THERAPEUTICS, INC. on the open market
Open‑market sale worth $241.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/28/2026ACC: 0001193125-26-129990
Officer· President, R&D
Since Feb 2026
-12K
Net shares
Net seller
$241.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12K acquired · 24K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12K
Price / share
$5.20
Trade value
$62.40K
% of position
10.7%
3/25/2026
112.62K→124.62K
Common Stock
Direct
Shares
−12K
Price / share
$20.11
Trade value
$241.32K
% of position
9.6%
3/25/2026
124.62K→112.62K
Total
Net shares
+0.00
Net value
-$178.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2026 | M · Option Exercise | +12K | $5.20 | $62.40K | 10.7% | 112.62K | 124.62K |
| Common Stock Direct | 3/25/2026 | S · Sale | −12K | $20.11 | $241.32K | 9.6% | 124.62K | 112.62K |
| Total | +0.00 | -$178.92K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12K shares
Shares
−12K
Strike price
5.20
Held after
460.50K
Exercisable
—
3/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12K shares | 3/25/2026 | M · Option Exercise | −12K | 5.20 | — | 460.50K |